Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe, North America, Latin America, Asia-Pacific, Middle East and Africa: 2,207 cases from 44 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by authority- Consumer Affairs Agency (消費者庁, CAA) €4.18m 100 % · 2 cases
What for?
by area of lawAll areas of law
Who?
by company- Anonymised companies €4.18m 100 % · 1 case
- P&G Japan G.K. (P&Gジャパン合同会社) – 0 % · 1 case
When?
per year, by date of decision| Period | Cases | Total |
|---|---|---|
| 2023 | 1 | €4.18m |
| 2024 | 0 | – |
| 2025 | 1 | – |
| 2026 | 0 | – |
2 cases
1 Aug 2025 P&G Japan G.K. (P&Gジャパン合同会社)P&G Japan: order over unsubstantiated anti-mould claims for a Febreze product Order
P&G Japan advertised its 'Febreze bathroom anti-mould' product (ファブリーズ お風呂用防カビ剤), among other things on the packaging from April 2022 to May 2023, by claiming that simply placing it in the bathroom would prevent black mould for around six weeks. The documents submitted did not substantiate this effect, so the advertising was deemed misleading; the order required a corrective notice, measures to prevent recurrence and cessation.
Anyone promising an effect must hold robust evidence before advertising; without it, the claim is deemed misleading.
Substantiating efficacy claims in advertising
- Authority / court
- Consumer Affairs Agency (消費者庁, CAA)
- Area of law
- Consumer protection and online retail · Misleading advertising and pricing
- Legal basis
- Art. 7 Abs. 1 und 2 i. V. m. Art. 5 Nr. 1 Act against Unjustifiable Premiums and Misleading Representations (不当景品類及び不当表示防止法, Gesetz Nr. 134/1962)
- Action
- Order
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Published
- 1 Aug 2025
- P&Gジャパン合同会社に対する景品表示法に基づく措置命令について (Eintrag, 01.08.2025) Press release of an authority
- News Release 01.08.2025 mit Maßnahmenanordnung 消表対第1255号 (PDF) Decision of an authority
Checked against the official source on 4 Oct 2026 · Direct link
Report an error
11 Apr 2023 a Japanese pharmaceutical manufacturerDrug maker: surcharge for unsubstantiated virus-removal claims for chlorine dioxide products €4.18m
From September 2018 to April 2022, the pharmaceutical manufacturer claimed on packaging, its own website, on television and in adverts on a video platform that products of its brand (room dispensers, clip-on sticks, sprays) remove airborne viruses and bacteria from indoor air by means of chlorine dioxide. The documents submitted did not substantiate this effect and the disclaimers on the packaging did not change the overall impression; the surcharge of 607,440,000 JPY is made up of individual amounts for five product groups, including 452,200,000 JPY for the room dispensers.
Hygiene claims need evidence for the advertised conditions of use; a reference to tests in a closed space does not rescue a sweeping advertising claim.
Substantiating efficacy and health claims in advertising
- Authority / court
- Consumer Affairs Agency (消費者庁, CAA)
- Area of law
- Consumer protection and online retail · Misleading advertising and pricing
- Legal basis
- Art. 8 Abs. 1 und 3 i. V. m. Art. 5 Nr. 1 Act against Unjustifiable Premiums and Misleading Representations (不当景品類及び不当表示防止法, Gesetz Nr. 134/1962)
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Culpability
- negligent
- Published
- 11 Apr 2023
Original amount 607,440,000 JPY, converted at the ECB reference rate of 11 Apr 2023.
- Consumer Affairs Agency (消費者庁, CAA), Veröffentlichung der Behörde (Entscheidung 2023) Decision of an authority
Checked against the official source on 7 Oct 2026 · Company name anonymised since 11 Apr 2025 · Direct link